Vaishali Pharma Share Price History and Returns 2017 to 2024
Vaishali Pharma Limited | |||
 | Price: ₹18.37 | ||
| 52 Week Low: ₹12.49 52 Week High: ₹24.91 | |||
| Market Capital: 163.36 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Vaishali Pharma Stock Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: Vaishali Pharma Recent Performance
- 3: Vaishali Pharma Stock Price Chart From 2017 to 2024
- 4: Vaishali Pharma Stock Price History Table From 2017 to 2024
- 5: Analyzing the Impact of Investing in Vaishali Pharma
- 5.1: Vaishali Pharma Stock Returns In Last 5 Years
- 6: Vaishali Pharma Returns vs Bank FD Returns
Vaishali Pharma Stock Highlights
As of 20 Dec 2024, Vaishali Pharma Stock price is ₹18.37 which is ₹6.54 below 52-week high of ₹24.91 and ₹5.88 above 52-week low of ₹12.49
52-Week High Low
- Vaishali Pharma 52-Week High is ₹24.91 occurred on 15 Oct 2024
- Vaishali Pharma 52-Week Low is ₹12.49 occurred on 05 Jun 2024
All Time High
- The all-time high or the highest price that Vaishali Pharma stocks have ever touched was ₹223.00 and this occurred on 14 Oct 2024.
- The highest closing price at which Vaishali Pharma stocks have ever closed was ₹212.85 recorded on 11 Oct 2024.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Vaishali Pharma Recent Performance
Over the past 15 trading days, the value of Vaishali Pharma's stock has increased by ₹2.17 (+13.40%). On 28 Nov 2024, its one share was worth ₹16.2 and by 20 Dec 2024, the value jumped to ₹18.37. During this period it created a highest high of ₹20.41 and lowest low of ₹16.00.
Click on legend items to show/hide respective price lines
Vaishali Pharma Stock Price Chart From 2017 to 2024
Click on legend items to show/hide respective price lines
Vaishali Pharma Stock Price History Table From 2017 to 2024
| Year | Vaishali Pharma | YOY Chg% | ↑High - ↓Low |
|---|---|---|---|
| 2024 | ₹18.37 | -90.0% | ↑ ₹20.39 ↓ ₹16.00 |
| 2023 | ₹181.95 | 31.2% | ↑ ₹198.00 ↓ ₹114.00 |
| 2022 | ₹138.65 | 286.7% | ↑ ₹162.00 ↓ ₹32.30 |
| 2021 | ₹35.85 | -48.9% | ↑ ₹77.05 ↓ ₹28.95 |
| 2020 | ₹70.05 | 115.5% | ↑ ₹70.30 ↓ ₹28.35 |
| 2019 | ₹32.50 | 1.7% | ↑ ₹33.85 ↓ ₹17.22 |
| 2018 | ₹31.94 | 5.5% | ↑ ₹44.94 ↓ ₹27.97 |
| 2017 | ₹30.25 | - | ↑ ₹43.75 ↓ ₹29.84 |
Analyzing the Impact of Investing in Vaishali Pharma
Vaishali Pharma Stock price in the year 2017 was ₹30.25. If you had invested ₹10,000 in Vaishali Pharma Stock in 2017, in 7 years, your investment would have reduced to ₹6,072 by the end of 2024. This represents a negative return of -39.3% from 2017 to 2024, with a compound annual growth rate (CAGR) of -6.9%.
Vaishali Pharma Stock Returns In Last 5 Years
- Its highest stock price in the last 5 years was: ₹198.00 and lowest was: ₹16.00
- Vaishali Pharma Stock price in 2019 was ₹32.50
- By 2024, its stock price dropped to ₹18.37
- It gave a negative return of over -43.5% with a CAGR of -10.8% over the last 5 years
- If you had invested ₹10,000 in Vaishali Pharma in 2019 then in 5 years, your investment would have declined to ₹5,652.3 by 2024.
Vaishali Pharma Returns vs Bank FD Returns
| Investment Type | Initial Amount | Final Value | Total Returns |
|---|---|---|---|
| Vaishali Pharma Shares | ₹10,000 | ₹6,072.72 | -39.3% |
| Bank FD (Simple Interest) | ₹10,000 | ₹14,200 | 42.0% |
| Bank FD (Compound Interest) | ₹10,000 | ₹15,036.3 | 50.4% |
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
